MedTrace Logo

A Study On Human Mass Balance And Biotransformation

NCT05040113 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2022-04-05

No results posted yet for this study

Summary

This study will evaluate the absorption,metabolism and excretion of CBP-307 in healthy chinese male subjects.

Conditions

  • Healthy Adult Subjects

Interventions

DRUG

CBP-307

CBP-307 capsules oral administration

Sponsors & Collaborators

  • Connect Biopharm LLC

    lead INDUSTRY

Principal Investigators

  • Suzhou Connect · Connect Biopharm LLC

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-04
Primary Completion
2021-10-30
Completion
2021-10-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05040113 on ClinicalTrials.gov